E2 enzymes are abnormally translated in a variety of cancers, being responsible for tumor progression and unfavorable biological and clinical characteristics, which emphasizes the relevance of UBE2C as a potential therapeutic target. The gene discussed is UBE2C; the disease is neoplasm.